Tactile Systems Technology (TCMD) Azione Prezzo
Tactile Systems Technology Prezzo
Il fatturato è cresciuto a un tasso composto del 19,9% annuo negli ultimi 12 anni, raggiungendo 329,52 Mio. USD. L'utile per azione è diminuito del 3,8% all'anno negli ultimi 12 anni. Il margine netto di Tactile Systems Technology si attesta al 5,8%, in aumento rispetto al -5,7% di alcuni anni fa. Gli analisti fissano un target di prezzo mediano di 40,00 USD, ovvero il 76,0% sopra il prezzo attuale. Su 10 analisti, 9 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Tactile Systems Technology Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Tactile Systems Technology Azione e analisi azionaria
Domande frequenti sull'azione Tactile Systems Technology
Tactile Systems Technology Inc is a medical technology company specializing in the development and commercialization of innovative medical devices to treat chronic diseases. Their business model focuses on providing cost-effective and patient-centered solutions for the management of lymphedema and other vascular conditions. By offering advanced and wearable compression therapy products, Tactile Systems aims to improve patients' quality of life and medical outcomes. With a strong emphasis on research and development, they continuously strive to enhance their product portfolio and expand their market reach. Tactile Systems' commitment to innovative healthcare solutions positions them as a leading player in the medical technology industry.
Tactile Systems Technology Inc is primarily active in the healthcare industry.
The main competitors of Tactile Systems Technology Inc in the market include companies such as Medtronic, Smith & Nephew, Hill-Rom Holdings, and Acelity.
Tactile Systems Technology Inc, commonly known as Tactile Medical, is a leading medical technology company based in Minneapolis, Minnesota. Founded in 1995, the company specializes in developing and providing at-home therapy devices and solutions for the treatment of lymphedema and chronic venous insufficiency. Tactile Medical's mission is to advance patient care by addressing unmet medical needs through innovative products and services. With its cutting-edge technology and dedication to improving patients' quality of life, Tactile Medical has become a trusted name in the medical community. Despite its relatively young age, the company has achieved significant growth and recognition, making it a promising investment option for those interested in the medical technology sector.
Tactile Systems Technology Inc has achieved several significant milestones. One notable accomplishment is its successful initial public offering in July 2016, which enabled the company to raise funds for future growth and expansion. Additionally, Tactile Systems has developed and launched innovative medical devices, including its Flexitouch system for lymphedema management. The company has received multiple awards and recognition for its contributions to the healthcare industry, such as being named to the Forbes 2017 list of America's Best Small Companies. Tactile Systems Technology Inc continues to focus on advancing patient care through its advanced medical solutions and dedication to innovation.
Tactile Systems Technology Inc is primarily present in the United States.
Tactile Systems Technology Inc is a leading medical technology company that specializes in developing and providing at-home therapy solutions. Their core values include patient-centricity, innovation, integrity, and collaboration. With a focus on improving the lives of patients with chronic diseases, Tactile Systems Technology Inc is dedicated to developing high-quality products that offer comfort and convenience. The company's corporate philosophy revolves around delivering effective and personalized healthcare solutions through a comprehensive understanding of patient needs. Tactile Systems Technology Inc consistently prioritizes patient well-being and strives to enhance their quality of life through continuous advancements in medical technology and patient care.
Gli analisti fissano attualmente un prezzo obiettivo medio di 40,00 USD per l’azione Tactile Systems Technology (mediana: 40,00 USD), pari a +76,0 % rispetto all’ultimo prezzo. Il consenso si basa su 10 giudizi di analisti.
10 analisti valutano attualmente l’azione Tactile Systems Technology: 9 raccomandano l’acquisto, 1 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Tactile Systems Technology ricavi pari a 362,39 Mio. USD e un utile per azione di 1,08 USD.
Convertita al tasso di cambio attuale, l’azione Tactile Systems Technology quota 20,25 EUR (22,73 USD).
L’azione Tactile Systems Technology (TCMD) è quotata su 3 borse, tra cui: NASDAQ (TCMD), Frankfurt (3L3.F), München (3L3.MU).
The company Tactile Systems Technology Inc is a US-American company based in Minneapolis that specializes in the development and distribution of medical devices for the treatment of peripheral circulation disorders. The company's business model is based on a wide range of non-invasive therapy devices that are used by patients to treat circulation disorders in the lower extremities. The Tactile product portfolio includes a range of devices, from light compression stockings to advanced systems with more comprehensive functions and applications. Tactile devices have been designed to improve circulation and support the healing of chronic wounds or injuries caused by poor circulation. The therapy devices are based on a patented technological approach - a unique pneumatic system that applies pulsating pressure to the lower extremities to improve circulation and reduce edema. The devices are designed to meet a variety of patient needs and can be used both in a clinical setting and at home. In addition to its therapy devices, Tactile also offers a range of services to support patients in the effective use of the devices and improve outcomes. These include patient and medical professional training programs, support services, and data analysis tools to ensure optimal therapy. The market for peripheral circulation disorders and chronic wounds is large and growing. According to estimates from the American Heart Association, more than 8.5 million people in the United States alone suffer from circulation disorders in the lower extremities, and this number is expected to continue rising due to factors such as increasing age and lifestyle diseases like diabetes. Tactile has managed to establish itself as a market leader in this segment by providing innovative products and services tailored to the needs of patients and medical professionals. The company has built a strong brand and made its products popular among doctors and clinics in the US. It also has a strong presence in the international market and has successfully expanded into new regions. Overall, Tactile offers its customers an integrated system of therapy devices and services aimed at improving the treatment of circulation disorders and maximizing patient outcomes. With its proven business model, strong brand presence, and commitment to product innovation and quality, Tactile is well positioned to continue growing successfully and increase its market share.
Il attesa fatturato di Tactile Systems Technology ammonta a 362,39 Mio. USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Tactile Systems Technology ammonta a 24,95 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Tactile Systems Technology è attualmente 21,00. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Tactile Systems Technology.
Il rapporto prezzo/fatturato (P/S) di Tactile Systems Technology è attualmente 1,45. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Tactile Systems Technology.
Il Quality Score AlleAktien per Tactile Systems Technology è 6/10.
L'ISIN di Tactile Systems Technology è US87357P1003. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Tactile Systems Technology è A2APEV. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Tactile Systems Technology è TCMD. Con questo simbolo di borsa vengono negoziate le azioni Tactile Systems Technology in borsa.
Azione Tactile Systems Technology
Gruppo di pari di Tactile Systems Technology
Tactile Systems Technology Ticker
Tactile Systems Technology FIGI
Altre metriche e analisi di Tactile Systems Technology in Deep Dive.
La nostra analisi azionaria dell'azione Tactile Systems Technology include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Tactile Systems Technology. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: